June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Evaluation of founder effect burden on recurrent variants in X-linked retinoschisis
Author Affiliations & Notes
  • Chelsea Bender
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, Bethesda, Maryland, United States
  • Ehsan Ullah
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, Bethesda, Maryland, United States
  • Amy Turriff
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, Bethesda, Maryland, United States
  • Santa J Tumminia
    Office of the Director, National Eye Institute, Bethesda, Maryland, United States
  • Paul A Sieving
    Ophthalmology Department, and Center for Ocular Regenerative Therapy, University of California Davis, Davis, California, United States
  • Catherine A Cukras
    Division of Epidemiology and Clinical Applications, National Eye Institute, Bethesda, Maryland, United States
  • Robert B Hufnagel
    Ophthalmic Genetics and Visual Function Branch, National Eye Institute, Bethesda, Maryland, United States
  • Footnotes
    Commercial Relationships   Chelsea Bender, None; Ehsan Ullah, None; Amy Turriff, None; Santa Tumminia, None; Paul Sieving, None; Catherine Cukras, None; Robert Hufnagel, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 1576. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chelsea Bender, Ehsan Ullah, Amy Turriff, Santa J Tumminia, Paul A Sieving, Catherine A Cukras, Robert B Hufnagel; Evaluation of founder effect burden on recurrent variants in X-linked retinoschisis. Invest. Ophthalmol. Vis. Sci. 2021;62(8):1576.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Pathogenic variants in the RS1 gene cause X-linked retinoschisis (XLRS), a rare inherited disease that results in childhood vision loss. Variants may be transmitted through multiple generations of unaffected carrier females before an affected male is discovered. Notably, certain RS1 variants are repeatedly reported in seemingly unrelated probands. Here, we investigate recurrent pathogenic variants to determine whether this phenomenon represents founder alleles or multiple mutation events.

Methods : Patients were consented and blood-derived DNA was obtained for analysis. Three polymorphic short tandem repeat (STR) markers and four single nucleotide polymorphism (SNP) markers surrounding the RS1 gene (~2 cM) were selected. Custom STR primers were designed with 5’6 FAM. Proband DNA was amplified with STR primers by Polymerase Chain Reaction (PCR) and analyzed by capillary electrophoresis. Alleles were called based on marker sizes. SNP markers were analyzed by Sanger sequencing. Visualization of haplotype geographical distribution was mapped by Zone Improvement Plan (ZIP) code using Python.

Results : XLRS probands (n=114) with one of the 13 most prevalent RS1 variants were analyzed. Nine variants (69%) had at least two probands with common variant-specific haplotypes over 7/7 markers (~2 cM). Twelve variants (92%) had two or more probands with shared alleles across at least 3/7 markers bilaterally adjacent to RS1 (~0.4 cM). Eleven variants (85%) demonstrated one or more geographic clusters for probands sharing variant-specific haplotypes. Recurrent variants with shared haplotype showed varying degrees of geographic clustering. Overall, 19 unique haplotypes of at least ~0.4 cM surrounding the RS1 gene comprised 87/114 (76%) of reportedly unrelated probands. Additionally, 65/87 (75%) probands with shared haplotypes of ~0.4 cM or more clustered in specific regions of the United States.

Conclusions : Examination of this large XLRS cohort for common RS1 haplotypes supports that the majority are explained by founder effect rather than multiple equivalent mutation events. This is beneficial for clinical variant classification and may be generalizable to other X-linked disorders.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×